These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24308790)

  • 1. Statin intolerance: more questions than answers.
    Guyton JR; Campbell KB; Lakey WC
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):1-3. PubMed ID: 24308790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Might the beneficial effects of statin drugs be related to their action on iron metabolism?
    Mascitelli L; Goldstein MR
    QJM; 2012 Dec; 105(12):1225-9. PubMed ID: 23097387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin intolerance.
    Ahmad Z
    Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of statin-intolerant patient.
    Arca M; Pigna G; Favoccia C
    Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.
    Al-Omran M; Mamdani MM; Lindsay TF; Melo M; Juurlink DN; Verma S;
    J Vasc Surg; 2008 Sep; 48(3):607-12. PubMed ID: 18585886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk associated with statin treatment.
    Kjekshus J
    J Am Coll Cardiol; 2008 Jan; 51(1):91; author reply 92. PubMed ID: 18174047
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin intolerance management: a systematic review.
    Meza-Contreras A; Wenczenovicz C; Ruiz-Arellanos K; Vesely EAK; Mogollon R; Montori VM
    Endocrine; 2023 Mar; 79(3):430-436. PubMed ID: 36459335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
    Bárczi G; Merkely B
    Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of statin therapy on infection related mortality in patients with atherosclerotic and cardiovascular disease.
    Mahajan R; Gupta R; Sharma A
    Anesth Analg; 2008 Jan; 106(1):352. PubMed ID: 18165612
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare-eligible patients diagnosed with atherosclerosis: patterns in statin therapy and lipid monitoring.
    Ohsfeldt RL; Gandhi SK; Fox KM
    Curr Med Res Opin; 2009 Jun; 25(6):1403-11. PubMed ID: 19422282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.
    Ahmed ST; Akeroyd JM; Mahtta D; Street R; Slagle J; Navar AM; Stone NJ; Ballantyne CM; Petersen LA; Virani SS
    J Am Heart Assoc; 2020 Nov; 9(22):e017915. PubMed ID: 33170055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefit of statins in non-cardiac vascular surgery patients.
    Stalenhoef AF
    J Vasc Surg; 2009 Jan; 49(1):260-5. PubMed ID: 19174265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.
    Mancini GB; Tashakkor AY; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng DS; Pearson GJ; Pope J
    Can J Cardiol; 2013 Dec; 29(12):1553-68. PubMed ID: 24267801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy in the perioperative period.
    Lander JS; Coplan NL
    Rev Cardiovasc Med; 2011; 12(1):30-7. PubMed ID: 21546886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and cardioprotection--more than just lipid lowering?
    Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.